Phathom Pharmaceuticals, Inc. - 8-K Filing
Phathom Pharmaceuticals reports Q2 net revenue of $74.3M, up 88% YoY, with operating expenses down 33% (Items: 2.02 Results of Operations and Financial Condition, 9.01 Financial Statements and Exhibits)
Tickers: $PHAT